NASDAQ: AVTEAerovate Therapeutics Inc Stock Ownership - Who owns Aerovate Therapeutics?
Insider buying vs selling
Have Aerovate Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| George A. Eldridge | Officer Title Chief Financial Officer and Treasurer | 2024-04-10 | 6,729 | $26.77 | $180.14kSell |
| George A. Eldridge | Officer Title Chief Financial Officer and Treasurer | 2024-04-10 | 7,500 | $2.14 | $16.05kBuy |
| George A. Eldridge | Officer Title Chief Financial Officer and Treasurer | 2024-04-10 | 771 | $27.57 | $21.25kSell |
| David S. Grayzel | Director | 2024-04-09 | 11,882 | $28.15 | $334.48kSell |
| George A. Eldridge | Officer Title Chief Financial Officer and Treasurer | 2024-04-01 | 12,495 | $2.14 | $26.74kBuy |
| Timothy P. Noyes | CHIEF EXECUTIVE OFFICER | 2024-04-01 | 10,000 | $2.14 | $21.40kBuy |
| Timothy P. Noyes | CHIEF EXECUTIVE OFFICER | 2024-04-01 | 4,502 | $28.97 | $130.40kSell |
| Timothy P. Noyes | CHIEF EXECUTIVE OFFICER | 2024-04-01 | 1,647 | $29.90 | $49.24kSell |
| Timothy P. Noyes | CHIEF EXECUTIVE OFFICER | 2024-04-01 | 2,851 | $31.02 | $88.45kSell |
| George A. Eldridge | Officer Title Chief Financial Officer and Treasurer | 2024-04-01 | 12,495 | $31.23 | $390.21kSell |
AVTE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AVTE insiders and whales buy or sell their stock.
AVTE Shareholders
What type of owners hold Aerovate Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 29.66% | 8,263,982 | $208.58M | Institution |
| Sofinnova Venture Partners X LP | 13.49% | 3,758,686 | $94.87M | Insider |
| Maha Katabi | 13.49% | 3,758,686 | $94.87M | Insider |
| Sofinnova Investments Inc | 13.49% | 3,758,686 | $94.87M | Institution |
| Atlas Venture Fund Xii LP | 8.35% | 2,327,909 | $58.76M | Insider |
| Tcg Crossover Management LLC | 7.90% | 2,201,274 | $55.56M | Institution |
| Atlas Venture Life Science Advisors LLC | 7.32% | 2,039,249 | $51.47M | Institution |
| Cormorant Asset Management LP | 7.29% | 2,030,691 | $51.25M | Insider |
| David S. Grayzel | 6.46% | 1,799,232 | $45.41M | Insider |
| Baker Bros Advisors LP | 6.03% | 1,680,517 | $42.42M | Institution |
AVTE vs Biotech Stocks
Aerovate Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.